Mirador Capital Partners »

Kailera Therapeutics shares owned by Mirador Capital Partners

Quarter-by-quarter ownership of Kailera Therapeutics (KLRA) shares owned by Mirador Capital Partners from 13F filings

Historical chart of Mirador Capital Partners investment in Kailera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kailera Therapeutics held by Mirador Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kailera Therapeutics by Mirador Capital Partners

Quarter filed Position value Share count Share price at filing
2026-09-30 $666k 58k 11.42

More positions owned by Mirador Capital Partners

Invesco Exch Trd Slf Idx Buletshs 2027 (BSJR)
Alphabet Cap Stk Cl C (GOOG)
Apple (AAPL)
Amazon (AMZN)
Invesco Exch Trd Slf Idx Invsco Blsh 26 (BSJQ)
Invesco Exch Trd Slf Idx Invsco 28 Hycorp (BSJS)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Palo Alto Networks (PANW)
Alphabet Cap Stk Cl A (GOOGL)
Chevron Corporation (CVX)
JPMorgan Chase & Co. (JPM)
Abbvie (ABBV)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)

View all positions for Mirador Capital Partners

Top funds holding Kailera Therapeutics

Bain Capital Investors
Bain Capital Life Sciences Investors
Rtw Investments
Canada Pension Plan Investment Board
Atlas Venture Life Science Advisors
FMR
BlackRock
Citadel Advisors
Adage Capital Partners GP
Wellington Management Company
Royalty Pharma Sub-Manager
Siren
Vanguard Capital Management
Vanguard Portfolio Management
Geode Capital Management

View all funds holding Kailera Therapeutics